Of the three high-risk fetuses, two had a heterozygous deletion of SMN1 E7 and E8 and one had a homozygous deletion of SMN1 E7 and E8, indicating that two fetuses were carriers, and one would have developed SMA after birth. Here, SMN1 is linked to proximal spinal muscular atrophy.